Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YZJ-1139 and Ticagrelor Drug Interaction Study
NCT06671470Phase 1Completed
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- Start
- Aug 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of fazamorexant in Insomnia, sponsored by Shanghai Haiyan Pharmaceutical Technology Co., Ltd. Primary endpoints: Maximum Observed Plasma Concentration at 48 hours, Area Under the Curve from Time Zero to Infinity at 48 hours and 1 more. Started Aug 2024; status: completed.
02
Drugs
fazamorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT06671470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06671470.